Drug name - Ryanodex

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8110225 EAGLE PHARMS Treatment using dantrolene Dec, 2022

(2 months from now)

US8604072 EAGLE PHARMS Treatment using dantrolene Dec, 2022

(2 months from now)

US8685460 EAGLE PHARMS Treatment using dantrolene Feb, 2023

(4 months from now)

US7758890 EAGLE PHARMS Treatment using dantrolene Jul, 2025

(2 years from now)

Drugs and Companies using DANTROLENE SODIUM ingredient

Treatment: For use in the treatment of malignant hyperthermia in conjunction with appropriate supportive measures and for the prevention of malignant hyperthermia in patients at high risk.

Dosage: FOR SUSPENSION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
250MG/VIAL FOR SUSPENSION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.